This study investigates the antibacterial efficacy of a combination treatment involving a short, membrane-disrupting antibiotic and a longer, membrane-intercalating compound against an antibiotic-resistant strain of a pathogenic bacterium. The research demonstrates how these compounds interact with bacterial membranes to enhance cell death.
Take suspensions of an antibiotic-resistant strain of a pathogenic bacterium.
Treat one suspension with a short, membrane-disrupting antibiotic compound and the other with both the short compound and a longer, membrane-intercalating compound.
Incubate both suspensions with agitation. These compounds mimic the lipid bilayer structure, enabling their spontaneous insertion into bacterial membranes.
The short compound spans only part of the membrane’s thickness, creating a structural mismatch. This mismatch strains the membrane, disrupts its integrity, and triggers cell death.
In the combination treatment, the longer compound embeds into and reorganizes the bilayer, facilitating the deeper insertion of the short compound and amplifying membrane disruption.
Perform serial dilutions of the suspensions and plate them onto agar.
Incubate to allow surviving cells to form colonies.
Count the colonies to determine the number of viable cells and observe the enhanced antibacterial efficacy of the combination treatment.
繁體中文
